Login
$EDIT
$1.96 +$0.09 (4.81%) After hours

$EDIT 4 SEC Filings

Filed On Filing
13 Nov 2026 Form 4: O'Neill Gilmore Neil, Director

Sold 21,164 shares ($51.1K)

13 Nov 2026 Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER

Sold 7,814 shares ($18.9K)

06 Nov 2026 Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER

Received 16,533 shares as a grant or award

06 Nov 2026 Form 4: O'Neill Gilmore Neil, Director

Received 43,567 shares as a grant or award

09 Sep 2026 Form 4: Ory Daniel Scott, EVP, Chief Medical Officer

Granted 950,000 Stock Option (right to buy)

04 Sep 2026 Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER

Sold 709 shares ($2.15K)

04 Sep 2026 Form 4: Parison Amy, SVP, Chief Financial Officer

Sold 453 shares ($1.38K)

04 Sep 2026 Form 4: O'Neill Gilmore Neil, Director

Sold 5,124 shares ($15.6K)

07 Aug 2026 Form 4: Ellinor Patrick Thomas Ii, Director

Granted 103,400 Stock Option (right to buy)

05 Aug 2026 Form 4: Parison Amy, SVP, Chief Financial Officer

Sold 678 shares ($1.75K)

29 Jul 2026 Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER

Sold 4,928 shares ($13.2K)

22 Jun 2026 Form 4: Connaughton Bernadette, Director

Granted 51,700 Stock Option (right to buy)

22 Jun 2026 Form 4: Hopfield Jessica, Director

Granted 51,700 Stock Option (right to buy)

22 Jun 2026 Form 4: Hirsch Andrew, Director

Granted 51,700 Stock Option (right to buy)

22 Jun 2026 Form 4: Scadden David, Director

Granted 51,700 Stock Option (right to buy)

22 Jun 2026 Form 4: Levy Elliott M., Director

Granted 51,700 Stock Option (right to buy)

05 Jun 2026 Form 4: Parison Amy, SVP, Chief Financial Officer

Sold 464 shares ($1.25K)

05 Jun 2026 Form 4: O'Neill Gilmore Neil, Director

Sold 15,380 shares ($41.5K)

05 Jun 2026 Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER

Sold 731 shares ($1.97K)

16 Mar 2026 Form 4: O'Neill Gilmore Neil, Director

Granted 1,015,200 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support